InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Patusky Christopher, 董事. Director active across 1 company, notably UNITED THERAPEUTICS Corp. In total, 32 reports have been logged. Split: 1 buy · 4 sells. Total volume traded: €2.7m. History available since 6 May 2021. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Patusky Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报32 总计
650 股0Common StockSEC:0001231427-26-000003:0
2,910 股@ US$101.800.0012% mcap3.6% 占其流量Common StockSEC:0001231427-26-000002:0
2,910 股@ US$569.000.0068% mcap20.4% 占其流量Common StockSEC:0001231427-26-000002:1
1,000 股@ US$101.800.0004% mcap1.1% 占其流量Common StockSEC:0001231427-26-000001:0
1,000 股@ US$578.880.0024% mcap6.5% 占其流量Common StockSEC:0001231427-26-000001:1
1,000 股@ US$101.801.3% 占其流量Common StockSEC:0001231427-25-000004:0
590 股0Common StockSEC:0001562180-25-005530:0
5,000 股@ US$175.4315.2% 占其流量Common StockSEC:0001562180-25-002636:0
5,000 股@ US$175.4316.1% 占其流量Common StockSEC:0001562180-25-000328:0
700 股@ US$175.432.1% 占其流量Common StockSEC:0001415889-24-022908:0
900 股0Common StockSEC:0001415889-24-019551:0
2,000 股@ US$76.362.7% 占其流量Common StockSEC:0001415889-24-017414:0
1,310 股@ US$76.261.7% 占其流量Common StockSEC:0001415889-24-013238:0
1,680 股@ US$224.006.6% 占其流量Common StockSEC:0001415889-24-005245:0
2,000 股@ US$88.033.1% 占其流量Common StockSEC:0001415889-23-014891:0
2,000 股@ US$88.033.1% 占其流量Common StockSEC:0001415889-23-012408:0
2,000 股@ US$88.033.0% 占其流量Common StockSEC:0001415889-23-007817:0
3 股@ US$130.240.0% 占其流量Common StockSEC:0001104659-23-055524:0
标准退出：2017年10月15日 (T+90)
2,000 股@ US$88.033.1% 占其流量Common StockSEC:0001415889-23-005017:0
2,000 股@ US$88.033.1% 占其流量Common StockSEC:0001415889-23-000308:0
1,500 股@ US$88.032.4% 占其流量Common StockSEC:0001415889-22-011591:0
1,500 股@ US$63.901.8% 占其流量Common StockSEC:0001415889-22-008821:0
2,000 股@ US$63.900.0005% mcap6.4% 占其流量Common StockSEC:0001415889-22-005241:0
2,000 股@ US$63.900.0005% mcap6.2% 占其流量Common StockSEC:0001415889-22-003960:0
2,000 股@ US$88.030.0007% mcap8.5% 占其流量Common StockSEC:0001415889-22-003051:0
32 条申报中的 25 条
About Patusky Christopher
PATUSKY CHRISTOPHER is Administrateur and a Director at UNITED THERAPEUTICS Corp, XNAS. He has 32 filings in total, and across the sampled recent filings from 2016-01-08 to 2026-07-13, purchases total 341 EUR and sales total 2654009 EUR, with the most frequent transaction nature shown as Levée d'options.
